| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/15/2004 | WO2004031174A1 Imidazol-1-ylmethyl pyridazine derivatives |
| 04/15/2004 | WO2004031171A1 Isoquinoline compounds and medicinal use thereof |
| 04/15/2004 | WO2004031169A1 Antibacterial agent having thiophene skeleton |
| 04/15/2004 | WO2004031162A1 Chirale oxazole-arylpropionic acid derivatives and their use as ppar agonists |
| 04/15/2004 | WO2004031161A1 Neurologically-active compounds |
| 04/15/2004 | WO2004031157A1 Antibacterial having pyrazole skeleton |
| 04/15/2004 | WO2004031151A1 Compounds capable of activating cholinergic receptors |
| 04/15/2004 | WO2004031149A1 Substituted gamma-phenyl-delta-lactams and uses related thereto |
| 04/15/2004 | WO2004031139A1 Cyclohexyl sulphones as gamma-secretase inhibitors |
| 04/15/2004 | WO2004031130A1 Use of cyclic depsipeptide as a chemotherapeutic agent against cancer |
| 04/15/2004 | WO2004031125A1 Spiro compounds, medicinal compositions containing the same and intermediates of the compounds |
| 04/15/2004 | WO2004031124A1 Cyclic nitromethyl acetic acid derivatives |
| 04/15/2004 | WO2004031123A1 Hydroxyphenylundecane derivatives, a process for their production and their use |
| 04/15/2004 | WO2004031118A1 Lpa receptor antagonists |
| 04/15/2004 | WO2004031117A1 Novel bioactive diphenyl ethene compounds and their therapeutic applications |
| 04/15/2004 | WO2004030803A1 Granulation system and process for producing powder using granulation system |
| 04/15/2004 | WO2004030709A1 Compositions with enhanced antimicrobial efficacy against e. coli |
| 04/15/2004 | WO2004030700A1 Solid preparation |
| 04/15/2004 | WO2004030692A1 Combined treatment or acromegaly with a growth hormon receptor antagonist and a dopamine agonist |
| 04/15/2004 | WO2004030685A2 Use of il-2 receptor antibodies to prevent toxicity associated with amphotericin b antimycotic therapy |
| 04/15/2004 | WO2004030684A2 Kavalactone product |
| 04/15/2004 | WO2004030683A1 Remedies |
| 04/15/2004 | WO2004030682A1 Pomolic acid, its isomers, derivatives and their uses, pharmaceutical composition method to prepare the pharmaceutical composition and method for treating multidrug resistant tumours |
| 04/15/2004 | WO2004030678A2 Polymer compositions containing bioactive agents and methods for their use |
| 04/15/2004 | WO2004030677A1 Compositions comprising highly purified amphotericin b |
| 04/15/2004 | WO2004030676A1 External preparation for inhibiting keloid formation |
| 04/15/2004 | WO2004030675A1 17β-ESTRADIOL/LEVONORGESTREL TRANSDERM PATCH FOR HORMONE REPLACEMENT THERAPY |
| 04/15/2004 | WO2004030674A1 Novel uses of prostaglandin d2, prostaglandin d2 agonist and prostaglandin d2 antagonist |
| 04/15/2004 | WO2004030673A1 Antibacterial medicinal composition of enhanced oral absorptivity |
| 04/15/2004 | WO2004030672A1 Use of 4 amino-quinazolines as anti cancer agents |
| 04/15/2004 | WO2004030671A2 Use of 4-amino-quinazolines as anti cancer agents |
| 04/15/2004 | WO2004030670A1 Potent inhibitor of hcv serine protease |
| 04/15/2004 | WO2004030669A1 Use of tricyclic amides for the treatment of disorders of calcium homeostasis |
| 04/15/2004 | WO2004030668A1 4-aminopiperidine derivatives, processes for their preparation and their use as medicaments |
| 04/15/2004 | WO2004030667A1 Nasal drop composition |
| 04/15/2004 | WO2004030666A1 Use of propionyl l-carnitine for the preparation of a medicament for the treatment of glaucoma |
| 04/15/2004 | WO2004030665A1 Transparent gel composition, for the administration of diclofenac sodium through the skin |
| 04/15/2004 | WO2004030664A2 New compounds for the inhibition of undesired cell proliferation and use thereof |
| 04/15/2004 | WO2004030663A1 Pharmaceutical composition comprising crystalline sibutramine methanesulfonate hemihydrate |
| 04/15/2004 | WO2004030662A1 Combination chemotherapy compositions and methods |
| 04/15/2004 | WO2004030661A2 Therapeutic compositions comprising a boron-containing compound |
| 04/15/2004 | WO2004030660A2 Compositions for treatment of prostate and other cancers |
| 04/15/2004 | WO2004030659A1 Sustained release porous microparticles for inhalation |
| 04/15/2004 | WO2004030658A1 Enteric composition for the manufacture of soft capsule wall |
| 04/15/2004 | WO2004030653A1 Compositions for preventing posterior capsular opacification and the use thereof |
| 04/15/2004 | WO2004030648A1 Fast releasing, solid administration form for oral application of active ingredients which are hard to dissolve |
| 04/15/2004 | WO2004030637A2 Treatment of obesity and other disorders associated with excessive food intake |
| 04/15/2004 | WO2004030635A2 Vasculostatic agents and methods of use thereof |
| 04/15/2004 | WO2004030633A2 Dosage escalation and divided daily dose of anti-depressants to treat neurological disorders |
| 04/15/2004 | WO2004030631A2 Anti-cancer and anti-infectious disease compositions and methods for using same |
| 04/15/2004 | WO2004030627A2 Synergistic methods and compositions for treating cancer |
| 04/15/2004 | WO2004030625A2 Synergistic methods and compositions for treating cancer |
| 04/15/2004 | WO2004030623A2 Nitroxide radioprotector formulations and methods of use |
| 04/15/2004 | WO2004030621A2 Method of treating cancer using adenosine and its analogs |
| 04/15/2004 | WO2004030618A2 Methods and reagents for the treatment of diseases and disorders associated with increased levels of proinflammatory cytokines |
| 04/15/2004 | WO2004030611A2 Non-nucleoside reverse transcriptase inhibitors |
| 04/15/2004 | WO2004030519A2 Thymic atrophy |
| 04/15/2004 | WO2004030457A1 Nodulisporic acid derivative spot-on formulations for combating parasites |
| 04/15/2004 | WO2004030448A1 RELATIONSHIP BETWEEN LIPOPROTEIN (a) AND ATHEROMA SCLEROSIS |
| 04/15/2004 | WO2004030440A2 Synthesis of oligomeric epicatechin and catechin-derived procyanidins |
| 04/15/2004 | WO2004017962A3 Tropical formulation comprising at least 5% of metronidazole in white petrolatum and its use in the anal and rectal region |
| 04/15/2004 | WO2004016607B1 Inhibition of phosphoinositide 3-kinase beta |
| 04/15/2004 | WO2004016254A3 Contraceptive methods and formulations |
| 04/15/2004 | WO2004014859A3 Process for preparing quinolin antibiotic intermediates |
| 04/15/2004 | WO2004014835A3 Resolvins: biotemplates for therapeutic interventions |
| 04/15/2004 | WO2004014391B1 Use of carboxamides for the treatment of tinnitus |
| 04/15/2004 | WO2004014317A3 Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases |
| 04/15/2004 | WO2004011632A3 Oligodendrocyte production from multipotent neural stem cells |
| 04/15/2004 | WO2004010987A3 Use of s1p receptor agonists in heart diseases |
| 04/15/2004 | WO2004009827A3 Preparation of microbial oil containing polyunsaturated fatty acids |
| 04/15/2004 | WO2004009558A3 Ureido substituted benzoic acid compounds, their use for nonsense suppression and the treatment of diseases caused by such mutations |
| 04/15/2004 | WO2004006850A3 3, 10, AND 12a SUBSTITUTED TETRACYCLINE COMPOUNDS |
| 04/15/2004 | WO2004006836A3 Treatment of neuropathic pain with 6h-pyrrolo[3,4-d]pyridazine compounds |
| 04/15/2004 | WO2004005321A3 Methods of inhibiting 4-hydroxyphenylpyruvate dioxygenase in a living system |
| 04/15/2004 | WO2004005309A3 Novel nonsteroidal anti-inflammatory substances, compositions and methods for their use |
| 04/15/2004 | WO2004005262A3 New neuropeptide y y5 receptor antagonists |
| 04/15/2004 | WO2004004774A3 Compositions comprising panthetine for the treatment of dyslipidemia |
| 04/15/2004 | WO2004004689A8 Compositions and methods for amelioration of human female sexual dysfunction |
| 04/15/2004 | WO2004004451B1 Methods of screening compounds for grk6 modulating activity |
| 04/15/2004 | WO2004003545A9 Methods and compositions for inhibition of multi-drug resistance by hyaluronan oligomers |
| 04/15/2004 | WO2004002477A8 2-(phenyl)-2h-pyrazole-3-carboxylic acid-n-4-(thioxo-heterocyclyl)-phenyl-amide derivatives and corresponding imino-heterocyclyl derivatives and relates compounds for use as inhibitors of the coagulation factors xa and/or viia for treating thromboses |
| 04/15/2004 | WO2004002398A3 Spherical pellet containing a water-soluble active ingredient |
| 04/15/2004 | WO2003106381A3 Human adam-10 inhibitors |
| 04/15/2004 | WO2003105583A3 Antimicrobial and antiviral compositions containing an oxidizing species |
| 04/15/2004 | WO2003103588A3 Methods of using artemisinin-like compounds to prevent or delay the appearance of cancer |
| 04/15/2004 | WO2003101988A3 Compounds and compositions for the treatment of diabetes and diabetes-related disorders |
| 04/15/2004 | WO2003092655A3 Use of active ingredient mixtures with azelaic acids and glycyrrhetic acids as anti-acne agents |
| 04/15/2004 | WO2003088956A8 Method for treating ileus with an alpha -ketoalkanoic acid or - ester or - amide |
| 04/15/2004 | WO2003082893A3 Theraputic methods and uses of sapogenins and their derivatives |
| 04/15/2004 | WO2003082392A3 Oxygenating agents for enhancing host responses to microbial infections |
| 04/15/2004 | WO2003082199A3 Platelet-activating factor antagonists as analgesic, anti-inflammatory, uterine contraction inhibiting, and anti-tumor agents |
| 04/15/2004 | WO2003080036B1 Use of a vanilloid as an anti-snoring element |
| 04/15/2004 | WO2003079883A3 Controlled laser treatment for non-invasive tissue alteration, treatment and diagnostics with minimal collateral damage |
| 04/15/2004 | WO2003077888A3 Compressed tablets comprising microcapsules with modified release |
| 04/15/2004 | WO2003075835A3 Compositions and methods for regulating thyroid hormone metabolism and cholesterol and lipid metabolism via the nuclear receptor car |
| 04/15/2004 | WO2003066064A3 Methods of resistant bacterial disease treatment using metal-complexed tetracycline antibiotics |
| 04/15/2004 | WO2003059951A3 Novel anti-igf-ir antibodies and uses thereof |
| 04/15/2004 | WO2003059352B1 Use of a novel class of drugs for the treatment of parasitic diseases |
| 04/15/2004 | WO2003059297A8 Dermatological topical compositions and a process for the preparation thereof |
| 04/15/2004 | WO2003056899A9 Nitric oxide donors for treatment of disease and injury |